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SFPQ and NONO suppress RNA:DNA-hybrid-
related telomere instability
Eleonora Petti1,2,6, Valentina Buemi1,2, Antonina Zappone1,2, Odessa Schillaci1, Pamela Veneziano Broccia1,2,
Roberto Dinami1,2,6, Silvia Matteoni 3, Roberta Benetti4,5 & Stefan Schoeftner1,2
In vertebrates, the telomere repeat containing long, non-coding RNA TERRA is prone to form
RNA:DNA hybrids at telomeres. This results in the formation of R-loop structures, replication
stress and telomere instability, but also contributes to alternative lengthening of telomeres
(ALT). Here, we identify the TERRA binding proteins NONO and SFPQ as novel regulators of
RNA:DNA hybrid related telomere instability. NONO and SFPQ locate at telomeres and have
a common role in suppressing RNA:DNA hybrids and replication defects at telomeres. NONO
and SFPQ act as heterodimers to suppress fragility and homologous recombination at telo-
meres, respectively. Combining increased telomere fragility with unleashing telomere
recombination upon NONO/SFPQ loss of function causes massive recombination events,
involving 35% of telomeres in ALT cells. Our data identify the RNA binding proteins SFPQ
and NONO as novel regulators at telomeres that collaborate to ensure telomere integrity by
suppressing telomere fragility and homologous recombination triggered by RNA:DNA
hybrids.
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Telomeres are heterochromatic structures that protecteukaryotic chromosome ends from an unwanted elicitationof a DNA damage response, telomere degradation and
aberrant recombination1–3. Incomplete replication of chromo-
some ends results in progressive shortening of telomeres, finally
leading to telomere dysfunction and irreversible cell cycle arrest,
also referred to as replicative senescence4. Core components of
vertebrate telomeric chromatin comprise the multi-protein
complex “shelterin” that has a key role in telomere protection
but also TERRA, a telomere repeat [UUAGGGn] containing long
non-coding RNA5,6. In human cancer cells, DNA methylation
sensitive promoters located in subtelomeres recruit RNA Poly-
merase II that uses the CCCTAA-repeat containing telomere
strand as template for the transcription of TERRA5–11. TERRA is
heterogeneous in size and a subfraction of TERRA has been
shown to localize to telomeric chromatin5,6,11. Accordingly,
TERRA is reported to act as scaffold that promotes the con-
centration of proteins or enzymatic activities at telomeres, thereby
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impacting on chromatin structure, chromosome end protection,
replication but also telomere maintenance by telomerase12–14.
Importantly, due to its G-rich sequence content, TERRA is prone
to form RNA:DNA hybrids with the C-rich telomeric strand. This
results in the displacement of the TTAGGG repeat containing
telomere strand, giving rise to so-called “R-loop” structures15–19.
In a natural context, R-loops are relevant for the regulation of
gene expression, chromatin structure and IgG class switch
recombination20–29. However, R-loops can represent obstacles to
DNA replication resulting in replicative stress, chromosome fra-
gility, DNA lesions and the activation of recombination-mediated
DNA repair that can finally lead to chromosome
rearrangements28,30–34. Recent studies showed that several bio-
logical pathways prevent or resolve RNA:DNA-hybrid structures
at eukaryotic telomeres. In yeast, loss of the 5′ to 3′ exonuclease,
Rat1p was linked with increased abundance of telomeric RNA:
DNA hybrids35. Loss of the THO complex in yeast results in
TERRA accumulation at telomeres, R-loop formation and
increased telomere recombination rates16. Further, lack of the flap
endonuclease 1 (FEN1), a canonical lagging strand DNA repli-
cation protein, leads to replicative stress at telomeres, caused by
increased telomeric RNA:DNA hybrids36. In yeast and human
cells, a particular relevance has been attributed to RNaseH that
antagonize R-loop formation by degrading RNA paired with
DNA15,17,35. In yeast, loss of RNaseH function results increased
abundance of telomeric R-loops, higher telomere recombination
rates, and a delayed onset of replicative senescence in telomerase-
negative cells15. Telomerase-negative human ALT cells, that
maintain telomere function by homologous recombination-based
“alternative lengthening of telomeres” (ALT), have been
demonstrated to display an increased abundance of R-loops and
RNaseH1 localization at telomeres17. Depletion of RNaseH1 in
these cells results in enhanced R-loop formation, replicative
stress, selective fragility at the telomeric CCCTAA-repeat con-
taining strand and increased extra-chromosomal telomere repeat
content17. This suggests that R-loop-related activation of
recombination-based DNA repair mechanisms can translate into
improved telomere repeat maintenance. This may be of special
relevance in telomerase-negative tumors that represent approxi-
mately 10–15% of all human tumors37,38.
Here, we set out to investigate novel pathways that impact on
RNA:DNA-hybrid-related regulation of telomere function. We
show that the TERRA RNA binding proteins NONO and SFPQ
are novel protein components of telomeric chromatin that have a
central role suppressing RNA:DNA-hybrid formation, DNA
replication defects, recombination, and DNA damage at telo-
meres of telomerase-positive and telomerase-negative cancer cells.
Remarkably, NONO and SFPQ antagonize different downstream
effects of telomeric RNA:DNA hybrids: NONO suppresses
telomere fragility; in contrast SFPQ represents a powerful barrier
to homologous recombination at telomeres. Accordingly, com-
bined loss of NONO and SFPQ results in a massive increase of
telomere recombination events and rapid alterations in telomere
length in both, telomerase-positive and negative cells. Our study
introduces NONO and SFPQ as novel regulators of RNA:DNA-
hybrid management that may open new inroads in defining
strategies that aim to target recombination-based pathways of
telomere maintenance in human cancer.
Results
NONO and SFPQ are TERRA interacting proteins. In order to
identify novel TERRA interacting proteins, we performed
TERRA RNA-pull-down experiments using mouse embryonic
stem cells that maintain telomeres via telomerase dependent
and independent telomere maintenance pathways39. Biotiny-
lated RNA oligonucleotides containing six UUAGGG repeats or
control oligonucleotides were incubated with nuclear extracts
obtained from mouse embryonic stem cells and recovered by
using stretpavidine coated agarose beads. Eluates from TERRA
and control RNA-pull-down experiments were processed by gel
electrophoresis. Silver staining revealed a series of proteins that
were specifically eluted from TERRA RNA oligonucleotides
(Fig. 1a). Mass spectrometric analysis revealed the identity of a
large set of reported TERRA interacting proteins, such as a
series of hnRNPs, as well as Fused in Sarcoma (FUS)40–42.
Importantly, the TERRA-pull-down approach identified the
Non-POU domain-containing octamer-binding protein
(NONO) and Splicing factor proline- and glutamine-rich
(SFPQ) as TERRA interacting proteins that have not yet been
studied in the context of telomere function. The specificity of
SFPQ and NONO for TERRA was validated by western blotting
using TERRA-pull-down eluates obtained from mouse
embryonic stem cells or H1299 non-small cell lung cancer cells
(Fig. 1b, c). NONO and SFPQ belong to the Drosophila beha-
vior/human splicing (DBHS) family protein that are defined by
highly conserved tandem N-terminal RNA recognition motifs
(RRMs), a NonA/paraspeckle domain (NOPS) and a C-terminal
coiled-coil43. NONO and SFPQ function is reported to depend
on the obligatory formation of homo- or heterodimers of both
proteins43. In line with this, immunoprecipitation experiments
using extracts from telomerase-positive H1299 and telomerase-
negative U-2 OS osteosarcoma cells that maintain telomeres via
the recombination-based “alternative lengthening of telomeres”
(ALT) pathway, confirm a direct interaction between NONO
and SFPQ in the cell model systems used in this study (Sup-
plementary Figure 1A, B). Confocal microscopy revealed that a
significant fraction of nuclear restricted SFPQ and NONO foci
Fig. 1 SFPQ and NONO interact with TERRA and localize to telomere repeats. a Silver staining of SDS-PAGE gels of eluates obtained from RNA-pull-down
experiments using biotinylated r[UUAGGG]6, biotinylated r[EGFP] RNA oligonucleotides or empty beads. Candidate TERRA interacting proteins identified
by mass spectrometry are indicated. NE, nuclear extract used as input; MW, molecular weight marker. b, c Western blotting analysis of RNA-pull-down
eluates using specific anti-NONO and anti-SFPQ antibodies confirms binding specificity of NONO and SFPQ for UUAGGG RNA repeats in mESCs (b) and
H1299 cells (c). FUS was previously reported to interact with TERRA42. Actin was used as loading control; NE, nuclear extract was used as input. Source
blots are available as Supplementary Figure 6 and 7. d Representative image of co-localization events (arrowheads) between NONO and the shelterin
protein TRF2 as determined by confocal microscopy in U-2 OS cells. e Representative image of co-localization events (arrowheads) between SFPQ and the
shelterin protein TRF1 by confocal microscopy in U-2 OS cells. f Quantification of d and e. Mean number of NONO-TRF2 and SFPQ-TRF1 co-localization
events per nucleus is shown. Error bars indicate standard deviation. n= number of analyzed nuclei. g Chromatin immunoprecipitation experiments (ChIP)
using U-2 OS cells and mouse anti-TRF2, rabbit anti-histone H3, rabbit anti-FUS, rabbit anti-NONO, and rabbit anti-SFPQ antibodies. Mouse and rabbit
control IgGs (IgG M/IgG R) were used as negative control. Serial dilutions of chromatin extract (input) prepared from U-2 OS cells were loaded.
h Quantification of three independent ChIP experiments, average enrichment of telomeric repeats is indicated; s.e.: short exposure; l.e.: long exposure.
f, h N, number of independent experiments, whiskers indicate standard deviation; a two-tailed Student’s t-test was used to calculate p-values. Source data
is provided as a Supplementary Information File. Scale bar, 1 μm. siRNAs listed in Supplementary Table 1
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co-localize with telomere repeat binding factor 2 (TRF2) or
telomere repeat binding factor 1 (TRF1) in U-2 OS interphase
cells (Fig. 1d–f). Immunoprecipitation experiments support the
interaction of NONO with TRF1 and TRF2 (Supplementary
Figure 2C, D). Confocal microscopy did not reveal a significant
co-localization between NONO or SFPQ with PML, suggesting
that the studied RNA binding proteins do not represent central
components of APBs (Supplementary Figure 1E, F). Performing
telomere ChIP we confirm association of SFPQ and NONO
with telomere repeat chromatin and exclude binding to AluY
b
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repeats (Fig. 1g, h). These data indicate that SFPQ and NONO
represent TERRA interacting proteins that localize to telomere
repeat sequences.
NONO and SFPQ cover multiple biological functions that
include transcriptional regulation, the formation of subnuclear
structures such as paraspeckles, but also DNA damage repair,
gene expression, cell cycle control, and circadian rhythm43,44. In
this study, we exclusively focus on the role of NONO and SFPQ
in controlling telomere function in human cancer cells.
NONO and SFPQ suppress telomere RNA:DNA hybrids and
damage. We next wished to understand whether NONO and
SFPQ impact on TERRA expression in U-2 OS cells that produce
TERRA at levels readily detectable by RT-PCR, Northern blotting
and RNA-FISH. Northern blotting and quantitative RT-PCR
using primers that amplify subtelomeric portions of TERRA
originating from chromosomes 1 and 21 or chromosomes 2, 10,
and 13 revealed that RNAi-mediated depletion of NONO or
SFPQ does not impact on total TERRA levels (Supplementary
Figure 2A-C; Supplementary Table 4). However, RNA-FISH
revealed that knockdown of NONO or SFPQ in U-2 OS ALT cells
significantly increased the number of TERRA foci per nucleus
(Fig. 2a, b). In line with this, the proportion of cells with high
TERRA foci number ( > 12) was increased in experimental cells
(Supplementary Figure 2D). Finally, depletion of SFPQ resulted
in a significant increase in TERRA RNA-FISH signal intensity
(Fig. 2a–c). These data suggest that NONO and SFPQ do not
impact on total TERRA levels but rather alter TERRA home-
ostasis at telomeres. Importantly, in NONO- or SFPQ-depleted
interphase U-2 OS cells TERRA foci showed increased co-
localization frequency with the DNA damage marker γH2AX
(Fig. 2d, e). Analysis of metaphase chromosomes by immuno
DNA-FISH showed increased localization of γH2AX at telomere
sequences at chromosome ends in experimental H1299 and U-2
OS cells (Supplementary Figure 2E-H). Activation of a DNA
damage response was validated by western blotting as shown by
increased γH2AX levels and stabilization of p53 in U-2 OS cells
(Supplementary Figure 2I, J). Together, this indicates that loss of
NONO and SFPQ leads to altered TERRA homeostasis and
promotes the formation of DNA damage at telomeres. Recent
studies showed that RNA:DNA hybrid and R-loop formation at
telomeres is linked with increased abundance of TERRA at
telomeric chromatin, without altering total TERRA lncRNA
levels17,36. To test whether NONO or SFPQ depletion enhances
RNA:DNA-hybrid formation between TERRA and the telomeric
C-strand, we performed co-immunocytochemistry using specific
anti-TRF1 antibodies and affinity purified S9.6 monoclonal
antibodies that detect RNA:DNA hybrids in a sequence inde-
pendent manner. Confocal microscopy revealed that RNAi-
mediated depletion of NONO or SFPQ significantly increased co-
localization frequencies between RNA:DNA hybrid and TRF1
foci in both, U-2 OS and H1299 cells (Fig. 2f–i). This result was
re-capitulated in RNAseH1 knockdown cells that have been
recently reported to show increased abundance of telomeric RNA:
DNA hybrids (Fig. 2f–i, Supplementary Figure 2K)17. RNAi-
mediated depletion of TRF1 from U-2 OS cells resulted in a
compete loss of immunostaining for TRF1, thus excluding cross
reactivity of the anti-TRF1 antibody in our experimental setup
(Supplementary Fig. 2L-M). Together, this indicates that NONO
and SFPQ have a role in suppressing TERRA:telomere RNA:
DNA-hybrid formation in telomerase-positive and negative can-
cer cells.
NONO and SFPQ suppress replication defects at telomeres.
RNA:DNA hybrids trigger the formation of R-loop structures that
represent obstacles during DNA replication, leading to replicative
stress, DNA damage, and increased recombination frequencies at
telomeres. Induction of replication defects at telomeres is linked
with the phosphorylation of ATR and the phosphorylation of
Serine 33 of the 32 kDa subunit of the Replication protein A
(RPA32pSer33), both surrogate markers for replication stress17.
As expected, induction of replicative stress by treatment of U-2
OS with hydroxyurea results in increased global
RPA32pSer33 staining (Fig. 3c). In line with increased RNA:
DNA-hybrid formation, we found that depletion of NONO or
SFPQ from U-2 OS cells is paralleled by an increased co-
localization of TERRA with phosphorylated RPA32 (Fig. 3a, b).
This effect is paralleled by a significantly increased co-localization
of TRF2 with RPA32pSer33 (Fig. 3c, d). Telomerase-positive
H1299 cells recapitulate increased RPA32Ser33 phosphorylation
at telomere in the absence of SFPQ. However, in loss of NONO
conditions the increase in TRF2/RPA32Ser33 co-localization rates
does not reach significance in H1299 cells (Supplementary Fig-
ure 3A, B). We propose that this is due to the increased resistance
of telomerase-positive cancer cells to replication stress at telo-
meres, as previously shown for HeLa and H1299 cells17,45.
Replicative stress is reported to trigger the phosphorylation of
Ataxia telangiectasia and Rad3-related (ATR). In line with this we
found an efficient phosphorylation of ATR at telomeres in SFPQ
knockdown U-2 OS or H1299 cells (Fig. 3e, f; Supplementary
Figure 3C, D). Remarkably, although loss of NONO triggers
RPA32Ser33 phosphorylation at telomeres in U-2 OS cells, we
were not able to observe increased telomeric ATR phosphoryla-
tion under these conditions. The role of NONO in enhancing
ATR-mediated DNA damage response signaling may provide an
explanation for this observation43,46.
We next wished to test whether increased RNA:DNA-hybrid
formation in NONO/SFPQ-depleted cells is directly linked to
phosphorylation of RPA32Ser33. To address this issue, we aimed
to rescue RPA32Ser33 phosphorylation levels in NONO- and
SFPQ-depleted cells by ectopically expressing a mCherry-tagged
version of human RNaseH1. As expected, co-depletion of NONO
Fig. 2 Depletion of NONO and SFPQ cause accumulation of RNA:DNA hybrids. a Representative images of TERRA RNA-FISH performed in U-2 OS cells
transiently transfected with NONO- or SFPQ-specific siRNAs or with a non-targeting control siRNA. b Quantification of the percentage of cells with more
than three TERRA foci per nucleus. c Quantification of TERRA signals intensity. Arbitrary fluorescence units (a.f.u.) are shown. Box plots: middle line
represents median, and the box extends from the 25th to 75th percentiles. The whiskers mark the 10th and 90th percentiles. p-values were calculated
using a two-tailed Mann–Whitney test. Median a.f.u. values and standard deviation are indicated; n= number of analyzed nuclei, N= number of analyzed
TERRA signals. d Representative images of TERRA RNA-FISH combined with anti-γH2AX immunostaing performed in U-2 OS cells transfected with
indicated siRNAs. Arrowheads indicate co-localization events. e Quantification of d; percentage of TERRA foci co-localizing with γH2AX per nucleus is
indicated. f, h Representative confocal microscope images of combined immunofluorescence using S9.6 anti-RNA:DNA hybrid and anti-TRF1 antibodies in
U-2 OS (f) or H1299 (h) cells transfected with indicated siRNAs. Arrowheads indicate co-localization events. g, i Quantification of telomeric RNA:DNA
hybrids per nucleus in U-2 OS (i) or H1299 (h) cells. For quantifications in b, e, g, i mean values are indicated; error bars indicate standard deviation; N=
number of independent experiments. n= number of analyzed nuclei. A two-tailed Student’s t-test was used to calculate statistical significance; p-values are
shown. Source data is provided as a Supplementary Information File. Scale bar, 1 μm. siRNAs listed in Supplementary Table 1
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and SFPQ resulted in recruitment of RPA32Ser33 to telomeres of
U-2 OS cells, indicative for replicative stress (Fig. 3g, h).
Importantly, this effect is eliminated upon transient expression
of RNaseH1 in NONO/SFPQ-depleted cells (Fig. 3g, h). Together,
these data indicate that NONO and SFPQ are TERRA interacting
proteins that have a crucial role in preventing RNA:DNA-hybrid
accumulation and R-loop-related replication defects at telomere
repeat sequences.
NONO and SFPQ regulate telomere leading strand fragility.
Increased RNA:DNA-hybrid levels at telomeres were shown to
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fuel R-loop formation and fragility of the telomeric leading (C-
rich) strand in vertebrate cells17,36. Telomeric R-loop structures
are prone to breakage, thus providing DNA substrates for
homologous recombination at yeast and human telomeres. In
order to understand the direct importance of NONO and SFPQ
for telomere integrity, we performed short term loss of func-
tion experiments using telomere chromosome orientation DNA-
FISH (CO-FISH). In this method BrdU incorporation during S-
Phase and subsequent enzymatic digestion of the neo-synthesized
DNA strand after UV treatment allows the selective detection of
the TTAGGG containing lagging telomeric strand or the
CCCTAA-repeat containing leading telomeric strand using dif-
ferentially labeled, telomere-strand-specific DNA-FISH probes
(Fig. 4a). This method allows to detect telomere-strand-specific
aberrations but also telomere recombination events (Figs. 4a, 5a).
RNAi-mediated depletion of NONO in U-2 OS cells significantly
increased the appearance of aberrantly shaped or multi-dotted
telomere signals the CCCTAA-repeat containing telomeric strand
in U-2 OS cells (+ 60%; Fig. 4b). Interestingly, loss of NONO
does not have an impact on telomere fragility at the TTAGGG
repeat containing lagging strand (Fig. 4b). This data is in line with
leading strand fragility triggered by increased RNA:DNA-hybrid
abundance in RNaseH1 or Flap endonuclease loss of function
cells17,36. As expected, ectopic expression of NONO reduced basal
levels of telomere lagging strand fragility (Fig. 4c). Remarkably,
loss of NONO in telomerase-positive cells results in telomeric
leading and lagging strand fragility; accordingly, NONO over-
expression reduces basic telomere fragility levels on both telomere
strands (Supplementary Figure 4A, B). Together, these data
identify NONO as novel suppressor of telomere fragility that has
a particular relevance in suppressing fragility at the telomeric
leading strand in ALT cells that are reported to be prone to
exhibit telomeric RNA:DNA hybrids and leading strand fragility.
NONO and SFPQ preferentially form heterodimers and have a
common function in suppressing TERRA:telomere-hybrid for-
mation. However, RNAi-mediated depletion of SFPQ had an
advert effect on telomere fragility in U-2 OS and H1299 cells
when compared to loss of NONO expression conditions. In fact,
loss of SFPQ selectively reduces leading strand fragility in both,
U-2 OS ALT and telomerase-positive H1299 cells (Fig. 4d; Sup-
plementary Figure 4C). SFPQ overexpression does not impact on
telomere fragility, suggesting that endogenous SFPQ expression
levels are sufficient to keep telomere fragility at sustainable levels
(Fig. 4e; Supplementary Figure 4D). Our data shows that SFPQ
and NONO, although reported to preferentially act as hetero-
dimer43, have different impact on telomere fragility. In particular,
NONO appears to be important to suppress telomere fragility; in
contrast, loss of SFPQ appears to activate molecular processes
that suppress telomere fragility.
SFPQ and NONO suppress recombination in cancer cells. To
better understand the different function of NONO and SFPQ in
the control of telomere stability we used telomere CO-FISH to
study recombination-based telomere sister chromatid exchange
(T-SCE), a reported downstream result of RNA:DNA-hybrid-
related R-loop formation at eukaryotic telomeres (Fig. 5a)15,17.
We found that NONO depletion does not significantly impact on
T-SCE in U-2 OS and H1299 cancer cells (Fig. 5b, c). In contrast,
SFPQ knockdown results in a significant increase in T-SCE fre-
quency in both, U-2 OS ALT and telomerase-positive H1299 cells
(Fig. 5b, c). This identifies SFPQ as a novel repressor of telomere
recombination in both, telomerase-positive and telomerase-
negative human cancer cells. Activation of ATR was recently
shown to promote homologous recombination, providing an
explanation for ATR phosphorylation in SFPQ, but not NONO
knockdown cells (Fig. 3e, f; Supplementary Figure 3C, D)47. We
next wished to better understand a potential contribution of
telomere fragility in NONO-depleted cells to the regulation of T-
SCE events. We found that in the context of increased telomere
fragility caused by NONO knockdown, co-depletion of SFPQ
resulted in a dramatic 18-fold increase of T-SCE that involves
35% of detectable telomeres (Fig. 5d, e). This effect was paralleled
by a rescue of telomere fragility in NONO/SFPQ double knock-
down cells (Fig. 5d–f). This suggests that telomere sister chro-
matid recombination may represent a mechanism to resolve
telomere fragility triggered by NONO depletion. This mechanism
can also explain reduced basal levels of telomeric leading strand
fragility in SFPQ-depleted H1299 and U-2 OS cells (Fig. 4d;
Supplementary Fig. 4C). In line with increased T-SCE frequency
in NONO/SFPQ-depleted cells we observed an increased fre-
quency of co-localization of TRF2 with Promyelocytic Leukemia
(PML) nuclear bodies and co-localization of RAD51 with TRF2 in
U-2 OS cells that were depleted for SFPQ (Fig. 5g–j). Accordingly,
we found significantly elevated TERRA–PML co-localization in
SFPQ knockdown cells, a feature reported for ALT cells (ref. 17
Supplementary Figure 5A, B). This is indicative for an enhanced
generation of alternative lengthening of telomeres-associated
PML nuclear bodies (APBs) and increased homologous recom-
bination at telomeres under SFPQ loss of function conditions. As
expected, depletion of NONO does not impact on APB frequency
in U-2 OS cells. Remarkably, although siRNA-mediated depletion
of SFPQ in telomerase-positive H1299 cells triggers T-SCE we did
not observe significantly increased APB numbers (Fig. 6e, f). This
suggests that loss of SFPQ can trigger telomere recombination in
telomerase-positive cancer cells; however, without efficiently
engaging APBs.
Together, our data indicate that NONO and SFPQ have
distinct roles in ensuring telomere stability. NONO suppresses
the generation of R-loop-related leading telomere fragility; in
Fig. 3 Depletion of NONO and SFPQ cause replication defects at telomeres in U-2 OS cells. a Representative images of TERRA RNA-FISH combined with
anti-RPA32pSer33 immunostaining performed in U-2 OS cells transfected with indicated siRNAs. Arrowheads indicate co-localization events.
b Quantification of a; percentage of TERRA foci co-localizing with RPA32pSer33 per nucleus is indicated. c Representative images of combined
immunofluorescence with anti-TRF2 and anti-RPA32pSer33 antibodies in U-2 OS cells transfected with indicated siRNAs. Arrowheads indicate co-
localization events. Induction of replicative stress by treating cells with hydroxyurea (5 mM) for 6 h was used as control for RPA32pSer33 staining.
d Quantification of TRF2/RPApSer33 co-localization events per nucleus. e Representative images of combined immunofluorescence using anti-TRF2 and
anti-pATR antibodies (S428) in U-2 OS cells transfected with indicated siRNAs. Arrowheads indicate co-localization events. f Quantification of TRF2/pATR
co-localization events per nucleus. g Representative images of combined immunofluorescence using anti-TRF2 and anti-RPA32pSer33 antibodies on U-2
OS cells transfected with indicated siRNAs and transiently expressing mCherry-RNase H1 or mCherry empty vector. Arrowheads indicate co-localization
events. h Quantification of the number of TRF2/RPA32pSer33 co-localizations per nucleus. For quantifications in b, d, f, h, mean values and standard
deviations are reported, error bars indicated standard deviation. N= number of independent experiments. n= number of analyzed nuclei. A two-tailed
Student’s t-test was used to calculate statistical significance; p-values are shown. Source data is provided as a Supplementary Information File. Scale bar, 1
μm. siRNAs listed in Supplementary Table 1
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contrast, SFPQ has a critical role in suppressing uncontrolled
recombination events triggered by the accumulation of telomere
R-loops and replication stress.
We further propose that increased telomere fragility in NONO-
depleted cells increases the availability of recombinogenic
substrates at telomeres that efficiently engage in homologous
recombination in the absence of SFPQ. We thus propose that
NONO and SFPQ collaborate to suppress RNA:DNA-hybrid
triggered telomere recombination in both ALT- and telomerase-
positive cancer cells.
SFPQ and NONO control telomere length in cancer cells.
Recombination-based ALT ensures telomere maintenance in
telomerase negative cancer cells37,38. Accordingly, the impair-
ment of pathways related to homologous recombination results in
alterations in telomere length homeostasis in ALT cells48,49.
Therefore, we were interested to study the role of SFPQ and
NONO in telomere length homeostasis in telomerase negative U-
2 OS ALT cells but also telomerase-positive H1299 cells. Quan-
titative telomere DNA-FISH revealed that siRNA mediated,
transient depletion of NONO or SFPQ in U-2 OS ALT cells for
3 days induces a 8% or 17% increase in telomere length,
respectively (Fig. 6a, b). This telomere elongation phenotype is
exacerbated upon combined depletion of NONO and SFPQ (+
35%) (Fig. 6a, b). This is in line with the dramatically increased T-
SCE frequency under these conditions (Fig. 5d, e). In contrast to
telomere elongation in U-2 OS cells, we found that unleashing
telomere recombination by single depletion of SFPQ or combined
depletion of NONO and SFPQ resulted a 21% reduction of tel-
omere length in telomerase-positive H1299 cells, respectively
(Fig. 6c, d). We thus hypothesize that enhancing T-SCE rates in
absence of functional APBs leads to an inefficient homologous
recombination process at telomeres in SFPQ knockdown H1299
cells, resulting a net loss of telomeric repeats (Fig. 6c, d). To test
this hypothesis, we aimed to rescue the telomere shortening
phenotype by stimulating the efficiency of homologous recom-
bination pathways in SFPQ-depleted H1299 cells. SFPQ was
depleted from telomerase-positive H1299 cells that were co-
treated with 5-Aza-2′-deoxycytidine to unleash recombination-
based telomere elongation. 5-Aza-2′-deoxycytidine treatment has
been reported to reduce subtelomeric DNA methylation, thus
driving recombination events in cancer cells, that are detectable
by telomere CO-FISH50. As expected, 5-Aza-2′-deoxycytidine
treatment lead to increased APB frequency in H1299 cells
Fig. 4 NONO and SFPQ regulate telomeric leading strand fragility of U-2 OS
cells. a Representative images and explanative models of leading strand and
lagging strand telomeric fragility as detected by Chromosome Orientation
FISH (CO-FISH). Fragile telomeres appear as multiple telomere signals.
b Quantification of leading strand fragility (left panel) and lagging strand
fragility (central panel) in U-2 OS cells transfected with NONO-specific
siRNA or a non-targeting control siRNA. Right panel, western blotting
showing NONO knockdown efficiency. c Quantification of leading strand
fragility (left panel) and lagging strand fragility (central panel) in U-2 OS
cells that stably overexpress FLAG-NONO or a control vector. Right panel,
western blotting showing ectopic expression of FLAG-tagged NONO.
d Quantification of leading strand fragility (left panel) and lagging strand
fragility (central panel) in U-2 OS cells transfected with SFPQ-specific
siRNA or a non-targeting control siRNA. Right panel, western blotting
showing SFPQ knockdown efficiency. e Quantification of leading strand
fragility (left panel) and lagging strand fragility (central panel) in U-2 OS
cells that stably overexpress myc-tagged SFPQ or an empty vector. Right
panel, western blotting showing expression of ectopic myc-SFPQ. For
quantifications in b–e, data points represent the percentage of fragile
telomeres per metaphase spread. Only chromosome ends with detectable
telomeres were considered for analysis. Metaphases from three
independent experiments were analyzed. Box plot diagrams (b–e): middle
line represents median; boxes extend from the 25th to 75th percentiles.
The whiskers mark the 10th and 90th percentiles. p-values were calculated
using a two-tailed Mann–Whitney test. Median fragility values and
standard deviation are indicated; n= number of analyzed telomere repeat
signals, N= number of analyzed metaphase spreads. siRNAs listed in
Supplementary Table 1. Source blots are available in Supplementary
Figure 8
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(Fig. 6e, f). This effect was found to be enhanced in SFPQ-
depleted and 5-Aza-2′-deoxycytidine-treated H1299 cells, sug-
gesting the activation of a functionally relevant subnuclear
compartment for the ALT pathway (Fig. 6e, f). Importantly,
under these conditions, quantitative telomere DNA-FISH
experiments revealed a reversion of the telomere shortening
phenotype of SFPQ-depleted H1299 cells, as demonstrated by a
47% telomere elongation in 5-Aza-2′-deoxycytidine-treated SFPQ
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knockdown H1299 cells, when compared to control cells (Fig. 6g,
h). This indicates that functional subnuclear APB compartments
are necessary to convert enhanced telomere recombination of
SFPQ-depleted telomerase-positive cells into a telomere elonga-
tion phenotype. We thus conclude that NONO and SFPQ are
novel regulators of telomere length in both telomerase-positive
and negative cancer cells.
Here, we show that RNA binding proteins NONO and SFPQ
are novel component of telomeric chromatin that suppress
replicative stress at telomeres by antagonizing the formation of
RNA:DNA hybrids. Remarkably, although preferentially acting in
heterodimers, NONO and SFPQ control different pathways that
result from the formation of RNA:DNA hybrids and R-loop
structures: NONO appears to suppress telomere fragility; in
contrast, SFPQ has a central role in suppressing homologous
recombination (Fig. 7). Combined loss of NONO and SFPQ
depletion results in a massive increase in homologous recombi-
nation and altered telomere length homeostasis. Altogether, our
data highlight a role for NONO and SFPQ in controlling RNA:
DNA-hybrid-related telomere instability and telomere length
homeostasis in both telomerase-positive and negative cancer cells.
Discussion
Here, we show that NONO and SFPQ are novel telomere repeat
associated proteins that collaborate to suppress RNA:DNA-
hybrid-related replicative stress, telomere fragility and telomere
recombination in both U-2 OS ALT cells and H1299 telomerase-
positive human cancer cells. Loss of NONO or SFPQ results in an
increased appearance of TERRA foci without affecting total
TERRA expression levels suggesting that trapping TERRA in
RNA:DNA-hybrid structures may increase the amount of
detectable TERRA transcripts at telomeres. In ALT cells, extra-
chromosomal telomeric repeats (ECTR) can constitute a notable
fraction of the total telomere repeat content, suggesting that a
fraction of NONO and SFPQ may also locate to this type of
telomere repeat sequences51. However, alterations at telomeres of
metaphase chromosomes observed in loss of function experiments
support a role for NONO and SFPQ at telomeres. We directly
show that loss of NONO and SFPQ mediates enhanced formation
of telomeric RNA:DNA hybrids in both, telomerase-positive and
negative human cancer cells. A common role of NONO and SFPQ
in suppressing RNA:DNA-hybrid abundance and replication
defects in human cancer cells is in accordance with several studies
that propose that NONO and SFPQ act on various aspects of RNA
metabolism by preferentially forming heterodimers43. In line with
the increased abundance of RNA:DNA hybrids, we observed
increased appearance of the classic DNA damage marker γH2AX
at telomere repeats of NONO- or SFPQ-depleted cells. This is in
line with independent studies that show an involvement of NONO
and SFPQ in promoting DNA damage pathways, including
homologous recombination, non-homologous end joining,
nucleotide excision repair, and interstrand cross-link repair43,44.
The fact that NONO and SFPQ contain multiple RNA binding
domains suggests an “RNA-based” role of NONO and SFPQ in
preventing RNA:DNA-hybrid-related DNA damage. Remarkably,
although acting as heterodimers, NONO and SFPQ have appar-
ently different roles in suppressing downstream events related to
RNA:DNA hybrids at telomeres. NONO appears to play an
important role in preventing fragility of the leading, CCCTAA-
repeat containing telomeric strand. In line with this, leading strand
fragility was previously shown to be a direct consequence of
telomeric RNA:DNA hybrids in different model systems17,36,52. In
contrast, CO-FISH analysis revealed that SFPQ acts as barrier to
homologous recombination at telomeres. Loss of SFPQ drives
RNA:DNA-hybrid formation, impaired replication and results in
dramatically increased recombination frequencies in the context of
ATR phosphorylation at telomeres of telomerase-positive and
ALT cancer cells. This effect is paralleled by a reduction of telo-
mere fragility, leading to the interesting speculation that homo-
logous recombination may help to rescue telomere fragility. Our
data show that SFPQ functions as barrier to homologous
recombination at telomeres. Phosphorylation of ATR in SFPQ
knockdown cells is in line with a recent report that demonstrated
that activation of ATR promotes homologous recombination47.
Remarkably, removing the SFPQ dependent recombination bar-
rier in the context of increased fragility mediated by NONO
depletion results in massive T-SCE events that involve 35% telo-
meres detectable by DNA-FISH in U-2 OS ALT cells. We propose
that increased chromosome fragility in the absence of NONO
leads to the generation of elevated numbers of recombinogenic
DNA products that efficiently engage in telomere recombination
when removing the recombination barrier SFPQ. Thus, NONO
and SFPQ have a direct role in suppressing RNA:DNA-hybrid-
related telomere fragility and recombination (Fig. 7). Given the
fact that NONO and SFPQ do not contain enzymatic activity and
may rather function as scaffold we propose that localization of
NONO or SFPQ to telomeres is necessary to recruit specific—yet
to define—factors that suppress RNA:DNA-hybrid-related telo-
mere fragility and recombination43,44. Homologous recombina-
tion represents a key pathway for the regulation of telomere length
homeostasis. In line with this, we found that NONO/SFPQ
knockdown in U-2 OS triggers increased T-SCE frequencies,
increased localization of RAD51 at telomere repeats as well as the
engagement of telomeres in APBs, thus resulting telomere elon-
gation. Under the same conditions, telomerase-positive H1299
Fig. 5 NONO collaborates with SFPQ to suppress recombination at telomeres. a Representative images and explanative models of telomeric sister
chromatid exchange (T-SCE) as detected by CO-FISH. b Quantification of T-SCEs in U-2 OS cells transfected with control siRNAs, NONO-specific siRNAs
(left panel), or SFPQ-specific siRNAs (right panel). c Quantification of T-SCEs in H1299 cells transfected with control siRNAs, NONO-specific siRNAs (left
panel), or SFPQ-specific siRNAs (right panel). d Representative images of CO-FISH experiments performed in U-2 OS cells transfected with indicated
siRNAs. e Quantification of T-SCEs in U-2 OS cells transfected with NONO-specific siRNA, or with both NONO- and SFPQ-specific siRNAs compared to
control cells. f Quantification of telomere fragility in U-2 OS cells transfected with NONO-specific siRNA, or with both NONO and SFPQ-specific siRNAs.
g Representative images of anti-TRF2 and anti-PML co-immunofluorescence to detect APBs in U-2 OS cells transfected with indicated siRNAs.
h Quantification of the number of APBs per nucleus of data shown in g. i Representative images of anti-TRF2 and anti-RAD51 co-immunofluorescence in U-
2 OS cells transfected with indicated siRNAs. j Quantification of RAD51-TRF2 co-localization events per nucleus of data shown in i. Box plot diagrams
(b, c, e, f): middle line represents median; boxes extend from the 25th to 75th percentiles. The whiskers mark the 10th and 90th percentiles. p-values were
calculated using a two-tailed Mann–Whitney test. Median T-SCE/fragility values and standard deviation are indicated; n= number of analyzed telomere
repeat signals, N= number of analyzed metaphase spreads. Panels h, j means (bars) and standard deviation (error bars) are reported. N= number of
independent experiments. n= number of analyzed nuclei. A two-tailed Student’s t-test was used to calculate statistical significance; p-values are shown.
Source data is provided as a Supplementary Information File. Scale bar, 1 μm. siRNAs listed in Supplementary Table 1
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cells, that lack functional APB compartments, show rapid telo-
mere shortening. Remarkably, telomere shortening can be rescued
by 5-Aza-2′deoxycytidine treatment that forces APB formation
and T-SCE in SFPQ loss of function cells50. This suggests that
functional APBs are important to convert increased T-SCE fre-
quencies in SFPQ loss of function cells into an overall increase in
telomere length.
Together, this identifies NONO and SFPQ as regulators of
telomere length homeostasis by controlling RNA:DNA-hybrid
abundance at telomeres. Given the relevance of RNA:DNA
hybrids in recombination and telomere length homeostasis,
NONO and SFPQ are expected to be of special relevance in
human tumors that maintain telomeres length via the ALT
pathway. In line with this, SFPQ mutations have been recently
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discovered by exome sequencing in human osteosarcoma, a
tumor type that is reported to use recombination-based
ALT as predominant pathway for telomere maintenance53.
We hypothesize that NONO and SFPQ act as platforms to
recruit factors that resolve DNA:RNA-hybrid structures
thereby suppressing fragility and recombination at telomeres
(Fig. 7). Understanding the function of the entire NONO/SFPQ
complex at telomeres is expected to open new avenues in
understanding the suppression of the ALT pathway in telomerase-
negative tumors and activation of the ALT pathway in telomerase
negative cells. These insights are expected to be highly relevant for
potential telomere-based anti-cancer therapies.
Fig. 6 NONO and SFPQ regulate telomere length homeostasis in human cancer cells. a Telomere length measurements by quantitative telomere DNA-FISH
on interphase U-2 OS cells after transient transfection with indicated siRNAs. Representative images are shown. b Telomere fluorescence intensity was
analyzed for each telomere of a. c Telomere length measurements by quantitative telomere DNA-FISH on interphase H1299 cells after transient
transfection with indicated siRNAs. Representative images are shown. d Telomere fluorescence intensity analyzed for each telomere of c. e Representative
images of combined immunofluorescence using anti-TRF2 and anti-PML antibodies in H1299 cells transfected with SFPQ-specific siRNA or a non-targeting
control siRNA. Cells were treated or not treated with 5-aza-2’-deoxycytidine (5-Aza). f Quantification of e; number of TRF2-PML co-localization events per
nucleus. Mean values (bars) and standard deviations (error bars) are reported. N= number of independent experiments. n= number of analyzed nuclei. A
two-tailed Student’s t-test was used to calculate statistical significance; p-values are shown. Source data is provided as Supplementary Information File.
g Representative images of telomere length measurements by quantitative telomere DNA-FISH on interphase H1299 cells transfected with SFPQ-specific
siRNA or a non-targeting control siRNA. Cells were treated or not treated with 5-aza-2’-deoxycytidine (5-Aza). h Telomere fluorescence intensity analyzed
for each telomere of g. For telomere length measurements, Box plot diagrams (b, d, h): middle line represents median arbitrary fluorescence units (a.f.u.),
boxes extend from the 25th to 75th percentiles. The whiskers mark the 10th and 90th percentiles. p-values were calculated using a two-tailed
Mann–Whitney test. Median a.f.u. values with standard deviation are indicated; n= number of analyzed telomere repeat signals, N= number of analyzed
interphase nuclei. Arbitrary fluorescence units (a.f.u.) are shown. Scale bar, 1 μm. siRNAs listed in Supplementary Table 1
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Fig. 7 A model for the role of NONO and SFPQ in controlling telomere stability. Top panel: NONO and SFPQ bind TERRA transcripts at telomeres and
control mechanisms that antagonize the accumulation of RNA:DNA hybrids, thereby stabilizing telomeres. Bottom panel: Loss of NONO and SFPQ leads to
the accumulation of RNA:DNA hybrids at telomeres, resulting in the displacement of the non-template telomere strand (G-strand) and R-loop formation.
Increased R-loop formation triggers replication defects, fragility, telomere damage and the exposition of recombinogenic telomeric DNA that engage in
telomere recombination events and result alterations in telomere length homeostasis. DNA pol, DNA polymerase; RNA pol II, RNA polymerase II
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Methods
Immunofluorescence. Cells were fixed in 4% paraformaldehyde (PFA) for 15 min,
followed by treatment with citrate buffer [0.1% (w/v), 0.5% Triton X-100] for 5 min
at room temperature. Cells were blocked for 45 min in 3% BSA, 0.1% Tween-20 in
1x PBS and incubated with primary antibodies (as indicated in Supplementary
Table 2) diluted in blocking solution at room temperature for 2 h. Cells were
washed in 0.3% BSA, 0.1% Tween-20 in 1x PBS and incubated with secondary
antibodies (Supplementary Table 3) for one hour at room temperature. Slides were
washed in 0.1% Tween-20 1XPBS, stained with DAPI (Sigma) and mounted in
Vectashield (Vector laboratories). For S9.6 immunofluorescence, cells were fixed
and permeabilized with ice-cold methanol for 10 min and acetone for 1 min on ice
as previously described23. Blocking, antibody and washing solutions were per-
formed in 4x SSC. Cells with at least 5 nuclear extra-nucleolar S9.6 foci were
analyzed. Co-localization events were quantified using ImageJ 1.46r or by visual
inspection. The Student’s t-test was used to calculate statistical significance.
RNA FISH. Cells were permeabilized with three consecutive steps (30 sec each) of
cytobuffer (100 mM NaCl, 300 mM Sucrose, 3 mM MgCl2, 10 mM Pipes pH 6.8),
cytobuffer/0.5% Triton-X, and cytobuffer. Cells were fixed for 10 min at room
temperature in ice-cold 4% paraformaldehyde (PFA) in 1x PBS and then dehy-
drated twice in ice-cold 70% ethanol for 2 min, ice-cold 90% ethanol for 1 min, and
ice-cold 100% ethanol for 1 min. Dried slides were incubated overnight with a Cy3-
labeled TERRA probe in a humid chamber (2x SSC, 50% formamide) at 37 °C.
Slides were washed once in 2x SSC for 3 min at room temperature and three times
in 2x SSC for 5 min at 37 °C. Subsequently, slides were transferred to 4x SSC and
mounted in Vectashield (Vector laboratories). The TERRA probe was labeled with
the FISH Tag DNA kit (Invitrogen).
Immunofluorescence combined with RNA FISH. Cell were permeabilized with
cytobuffer as described for RNA-FISH and then subjected to the immuno-
fluorescence protocol. Used primary and secondary antibodies are indicated in
Supplementary Table 2, 3. After the washing step for the secondary antibody, cells
were fixed at room temperature for 2 min with 4% paraformaldehyde (PFA),
dehydrated and RNA-FISH was performed. Co-localization of foci from FISH and
immunostainings were quantified by visual inspection.
Telomere DNA-FISH. DNA-FISH was carried out as previously described54. Cells
were fixed with 4% paraformaldehyde for 10 min at RT. After three washes with 1x
PBS for 5 min, slides were dehydrated by washing in 70%, 90%, and 100% ethanol
for 5 min each. Slides were allowed to dry for 10 min at RT. A Cy3-labeled
(CCCTAA)3 probe was added to sample and after denaturation at 80 °C for 3 min,
the slides were incubated for 2 h at room temperature in a humid chamber. Sub-
sequently, the slides were washed under agitation, twice with FISH solution (70%
formamide, 10 mM Tris pH 7.2, 0.1% BSA) for 15 min at room temperature and
three times with 0.01% Tween-20 in 1x TBS at room temperature. Slides were then
dehydrated with washes in 70%, 90%, and 100% ethanol. Samples where mounted
with Vectashield (Vector laboratories). Interphase nuclei were analyzed using spot
IOD analysis (TFL-TELO) software. A Mann–Whitney was used to calculate sta-
tistical significance.
Chromosome prientation FISH (CO-FISH). Confluent experimental cells were
subcultured in the presence of 5′-bromo-2′-deoxyuridine (BrdU, 10 µM; Sigma)
and cultivated for 18–20 h. Colcemid was added during the final period of BrdU
treatment (U-2 OS, 0.2 µg/m 3 h; H1299, 1 µg/ml for 2 h). Cells were recovered and
metaphases prepared as previously described54. CO-FISH was performed as pre-
viously described55,56 using first a (CCCTAA)3 probe labeled with Cy3 and then a
second (TTAGGG)3 probe labeled with FITC. Samples were processed as described
for DNA-FISH.
Reporting summary. Further information on experimental design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The data that support the findings of this study are available from the corresponding
author upon reasonable request. Source data for western blot and ChIP experiments in
Figs. 1 and 4 are available in the Supplementary Information File.
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